To hear about similar clinical trials, please enter your email below
Trial Title:
Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer
NCT ID:
NCT06246955
Condition:
Hematopoietic and Lymphoid System Neoplasm
Malignant Solid Neoplasm
Conditions: Official terms:
Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Supportive Care
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
Behavioral Intervention: Group Therapy Session
Description:
Attend virtual group therapy sessions
Arm group label:
Supportive care (group therapy sessions)
Other name:
Behavior Conditioning Therapy
Other name:
Behavior Modification
Other name:
Behavior or Life Style Modifications
Other name:
Behavior Therapy
Other name:
Behavioral Interventions
Other name:
Behavioral Modification
Other name:
Behavioral Therapy
Other name:
Behavioral Treatment
Other name:
Behavioral Treatments
Intervention type:
Other
Intervention name:
Survey Administration
Description:
Ancillary study
Arm group label:
Supportive care (group therapy sessions)
Summary:
This clinical trial tests how well acceptance and commitment therapy and compassion based
virtual group therapy works to improve psychological wellbeing, such as compassion,
understanding, and flexibility, in patients with cancer. Receiving a cancer diagnosis,
undergoing cancer treatment, and living with cancer- or treatment-related symptoms have
often been found to be associated with elevated distress and decreased quality of life
for individuals, even when the disease is stable or in remission. Acceptance and
Commitment Therapy (ACT) has demonstrated considerable benefits on individuals' quality
of life, psychological flexibility, and amelioration of psychological distress following
a cancer diagnosis and in the face of uncertainty, loss, and challenges associated with
cancer.
Detailed description:
PRIMARY OBJECTIVES:
I. To assess if participants perceive compassion and understanding by the provider who
facilitates the virtual group intervention.
II. To assess if participation in the ACT-based group intervention is associated with
increases in patients' self-reported psychological flexibility as well as amelioration in
psychological and physical distress.
SECONDARY OBJECTIVE:
I. To assess if participation in the ACT-based group intervention is associated with
increases in patients' self-reported mindfulness, self-compassion, meaning and purpose,
and posttraumatic growth.
OUTLINE:
Patients attend acceptance and commitment virtual group therapy sessions over 1.5 hours
each, once a week for 6 weeks.
After completion of study treatment, patients are followed up at 1 month.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Being an adult (18 years or older)
- Being a patient of Mayo Clinic Arizona
- Having a cancer diagnosis, having treatment planning in progress, undergoing
cancer-related treatment, or having completed cancer within the past 2 years (in
recent survivorship
- Experiencing stress or challenges related to cancer and having treatment goals that
align with the purpose of the group
- Having self reported proficiency to read/write/speak English
- Expressing interest and commitment to attend all six virtual group sessions
Exclusion Criteria:
- Patients' inability to take part in and benefit from the virtual group therapy based
on clinical judgment of the psychosocial oncology team member who completes the
psychosocial evaluation, which may include having active suicidal or homicidal
intent, experiencing uncontrolled psychotic symptoms, having untreated personality
disorder/characteristics that are likely disturbing in a group setting, and/or
having moderate to severe cognitive impairments
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Mayo Clinic in Arizona
Address:
City:
Scottsdale
Zip:
85259
Country:
United States
Status:
Recruiting
Contact:
Last name:
Clinical Trials Referral Office
Phone:
855-776-0015
Email:
mayocliniccancerstudies@mayo.edu
Investigator:
Last name:
Chun Tao, Ph.D., L.P.
Email:
Principal Investigator
Start date:
January 8, 2024
Completion date:
December 31, 2027
Lead sponsor:
Agency:
Mayo Clinic
Agency class:
Other
Source:
Mayo Clinic
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06246955
https://www.mayo.edu/research/clinical-trials